-
Product Insights
Dual Specificity Protein Kinase TTK – Drugs In Development, 2023
Global Markets Direct’s Dual Specificity Protein Kinase TTK provides in depth analysis on Dual Specificity Protein Kinase TTK targeted pipeline therapeutics. The report provides comprehensive information complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in Dual...
-
Product Insights
Dual Specificity Protein Kinase CLK2 – Drugs In Development, 2023
Global Markets Direct’s Dual Specificity Protein Kinase CLK2 provides in depth analysis on Dual Specificity Protein Kinase CLK2 targeted pipeline therapeutics. The report provides comprehensive information complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in Dual...
-
Product Insights
Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A – Drugs In Development, 2023
Global Markets Direct’s Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A provides in depth analysis on Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A targeted pipeline therapeutics. The report provides comprehensive information complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key...
-
Product Insights
Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1B – Drugs In Development, 2023
Global Markets Direct’s Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1B provides in depth analysis on Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1B targeted pipeline therapeutics. The report provides comprehensive information complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key...
-
Product Insights
Dual Specificity Mitogen Activated Protein Kinase Kinase 1 – Drugs In Development, 2023
Global Markets Direct’s Dual Specificity Mitogen Activated Protein Kinase Kinase 1 provides in depth analysis on Dual Specificity Mitogen Activated Protein Kinase Kinase 1 targeted pipeline therapeutics. The report provides comprehensive information complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview...
-
Product Insights
Dual Specificity Mitogen Activated Protein Kinase Kinase 2 – Drugs In Development, 2023
Global Markets Direct’s Dual Specificity Mitogen Activated Protein Kinase Kinase 2 provides in depth analysis on Dual Specificity Mitogen Activated Protein Kinase Kinase 2 targeted pipeline therapeutics. The report provides comprehensive information complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview...
-
Product Insights
Phosphatidylinositol 3,4,5 Trisphosphate 3 Phosphatase And Dual Specificity Protein Phosphatase PTEN – Drugs In Development, 2023
Global Markets Direct’s Phosphatidylinositol 3,4,5 Trisphosphate 3 Phosphatase And Dual Specificity Protein Phosphatase PTEN provides in depth analysis on Phosphatidylinositol 3,4,5 Trisphosphate 3 Phosphatase And Dual Specificity Protein Phosphatase PTEN targeted pipeline therapeutics. The report provides comprehensive information complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases....
-
Product Insights
Khulna Dual Fuel Power Plant
Khulna Dual Fuel Power Plant is a thermal project located in Khulna, Bangladesh. The project is owned by Harbin Electric International Co Ltd; Jiangsu Etern Co Ltd and is developed by Bangladesh Power Development Board. The project is currently under construction. Empower your strategies with our Khulna Dual Fuel Power Plant report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business...
-
Product Insights
Mymensingh Dual Fuel Power Plant
Mymensingh Dual Fuel Power Plant is a thermal project located in Dhaka, Bangladesh. The project is owned and being developed by Rural Power Co Ltd. The project is at the permitting stage. Empower your strategies with our Mymensingh Dual Fuel Power Plant report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain...
-
Product Insights
Hassi R’Mel Dual Fuel Power Plant
Hassi R’Mel Dual Fuel Power Plant is a thermal project located in Laghouat, Algeria. The project is owned by Societe Algerienne de Production de l’Electricite and was developed by GE Power; Metka SA. The project came online in 2015. Empower your strategies with our Hassi R’Mel Dual Fuel Power Plant report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day...